Psilocybin therapy for depression and alcohol use disorder
Treatments studied
Part of Mental health clinical trials.
This study tests whether a drug called psilocybin, given along with therapy, can help people who have both major depression and alcohol use disorder. You may be a good fit if you have tried other treatments or don't want to start new medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old
- Have both major depression and alcohol use disorder that are at least moderate in severity
- Be willing to stop taking current antidepressants, antipsychotics, or anti-craving medications for at least 2 weeks before the study
- Not have certain heart problems, liver disease, or uncontrolled high blood pressure
- Not have a history of psychosis, bipolar disorder, or certain personality disorders
- Not have used hallucinogens in the past 5 years or more than 10 times total
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a single dose of psilocybin (a psychedelic compound) can help treat depression by looking at brain changes on MRI. It is designed for people with moderate-to-severe depression who have not responded well to other treatments.
This trial tests whether a psilocybin (magic mushroom) therapy session can help people with alcohol use disorder reduce their drinking. You'll have one or two guided sessions with a therapist, plus support before and after, to see if it helps you change your drinking habits.
This study tests whether psilocybin, a psychedelic drug, combined with therapy can help people reduce or stop drinking. It aims to understand how psilocybin affects the brain and behavior in people with alcohol use disorder.
This study tests whether psilocybin (a psychedelic compound) can help people with severe alcohol use disorder stay sober longer, especially if they also have depression. Participants receive guided psilocybin sessions alongside counseling to reduce the risk of returning to heavy drinking.
This trial tests whether psilocybin, a psychedelic substance, combined with talk therapy can help people with severe alcohol use disorder stop or reduce drinking. Participants will first complete a 4-week inpatient detox program before receiving psilocybin in a supervised setting.
This trial tests whether a single dose of psilocybin (the active ingredient in 'magic mushrooms') combined with therapy can help people with severe alcohol use disorder reduce or stop drinking. It's for people who've recently completed detox and are ready to commit to a structured program in Boston.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.